ctDNA Clinical Trials

22 clinical trials for ctDNA across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM) — RECRUITING
• Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer — RECRUITING · PHASE2
• A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer — RECRUITING · PHASE2
• Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer — RECRUITING · PHASE2
• Randomized Trial of Plasma ctDNA Methylation-Guided Adjuvant Therapy in T4N0 and Low-Risk Stage III Colorectal Cancer — RECRUITING · PHASE2
• A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring — RECRUITING · NA
• ctDNA-guided Treatment Decision-making — RECRUITING · PHASE2
• Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy — RECRUITING · PHASE1
• A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening — RECRUITING
• SMC Radiation Oncology SABR Cohort for Oligometastasis — RECRUITING
• French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC) — RECRUITING
• A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy — ACTIVE_NOT_RECRUITING · PHASE2
• ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial — ACTIVE_NOT_RECRUITING · NA
• Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study) — WITHDRAWN
• Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma — NOT_YET_RECRUITING · PHASE2
• Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging — NOT_YET_RECRUITING · NA
• A Study of Tumor-Agnostic MRD Detection in Stage III Colorectal Cancer — NOT_YET_RECRUITING
• Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description — ACTIVE_NOT_RECRUITING
• Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions — NOT_YET_RECRUITING
• Prognostic Study of Via Dynamic Change of dT-DNA in Drainage Fluid After Radical Prostatectomy — NOT_YET_RECRUITING
• Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapy — OTHER
• The Implication of ctDNA in the Recurrence Surveillance of Stage II and III Colorectal Cancer — OTHER

Refine this search